Menu

Generics/News

picture 77

Watson now third largest generics company with Actavis acquisition

Generics/News | Posted 27/04/2012

Watson Pharmaceuticals (Watson) has confirmed a definitive agreement to acquire privately-owned generics firm Actavis for an upfront payment of Euros 4.25 billion. The acquisition of Actavis makes Watson the third largest generics company in the world, with US$8 billion in combined revenue expected during 2012.

picture 68

US Supreme Court rules against generics delaying tactics

Generics/News | Posted 23/04/2012

On 17 April 2012, the US Supreme Court ruled in favour of India-based generics company Sun Pharma in its case against Danish pharmaceutical company, Novo Nordisk, a case that could have provided a route for brand-name drug companies to delay generics competition.

picture 66

FDA approves generic vancomycin capsules

Generics/News | Posted 23/04/2012

On 11 April 2012 India-based Strides Arcolab (Strides) announced that it had received FDA approval for its generic version of Baxter’s antibiotic Vancocin (vancomycin).

picture 66

Generic quetiapine launched but the fight goes on

Generics/News | Posted 13/04/2012

The news of AstraZeneca’s failed attempts to delay generic competition for its blockbuster antipsychotic drug Seroquel (quetiapine fumarate) has caused a gold rush among generic companies, who are falling over each other to launch their generic versions.

picture 65

FDA approves first generics to treat high blood pressure and kidney disease

Generics/News | Posted 13/04/2012

On 2 April 2012, Teva Pharmaceutical Industries (Teva) announced that it had launched generic versions of sanofi-aventis’ high blood pressure treatments Avapro (irbesartan) and Avalide (irbesartan and hydrochlorothiazide) in the US.

picture58

AstraZeneca losing fight against generic quetiapine

Generics/News | Posted 06/04/2012

AstraZeneca’s is losing the fight it seems to protect its blockbuster antipsychotic drug Seroquel (quetiapine fumarate).

picture60

Novartis introduces branded generic tacrolimus

Generics/News | Posted 06/04/2012

Novartis announced on 3 April 2012 that it had launched a branded generic version of Astellas Pharma’s immunosuppressant Prograf (tacrolimus).

picture52

FDA approves first generic ibandronate sodium osteoporosis drugs

Generics/News | Posted 30/03/2012

FDA announced on 19 March 2012 the approval of the first generics of GlaxoSmithKline’s and Roche’s postmenopausal osteoporosis drug Boniva (ibandronate sodium).

picture45

AstraZeneca sues FDA over generic quetiapine

Generics/News | Posted 23/03/2012

In an attempt to prevent competition from generics to its blockbuster anti-psychotic drug Seroquel (quetiapine fumarate), pharma giant AstraZeneca has filed a lawsuit against FDA.